These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 22886632)

  • 21. High expression of S100A2 predicts poor prognosis in patients with endometrial carcinoma.
    Zhang Q; Xia T; Qi C; Du J; Ye C
    BMC Cancer; 2022 Jan; 22(1):77. PubMed ID: 35042454
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibin-alpha subunit is an independent prognostic parameter in human endometrial carcinomas: analysis of inhibin/activin-alpha, -betaA and -betaB subunits in 302 cases.
    Mylonas I; Worbs S; Shabani N; Kuhn C; Kunze S; Schulze S; Dian D; Gingelmaier A; Schindlbeck C; Brüning A; Sommer H; Jeschke U; Friese K
    Eur J Cancer; 2009 May; 45(7):1304-1314. PubMed ID: 19231155
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Overexpression of ephrinB2 and EphB4 in tumor advancement of uterine endometrial cancers.
    Alam SM; Fujimoto J; Jahan I; Sato E; Tamaya T
    Ann Oncol; 2007 Mar; 18(3):485-90. PubMed ID: 17108150
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Elevated expression of HABP1 is a novel prognostic indicator in triple-negative breast cancers.
    Wang J; Song Y; Liu T; Shi Q; Zhong Z; Wei W; Huang S; Pang D
    Tumour Biol; 2015 Jun; 36(6):4793-9. PubMed ID: 25794640
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabolic syndrome is an independent prognostic factor for endometrial adenocarcinoma.
    Ni J; Zhu T; Zhao L; Che F; Chen Y; Shou H; Yu A
    Clin Transl Oncol; 2015 Oct; 17(10):835-9. PubMed ID: 26260911
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictive significance of combined LAPTM4B and VEGF expression in patients with cervical cancer.
    Meng F; Tan S; Liu T; Song H; Lou G
    Tumour Biol; 2016 Apr; 37(4):4849-55. PubMed ID: 26526574
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Decreased carbonyl reductase 1 expression promotes malignant behaviours by induction of epithelial mesenchymal transition and its clinical significance.
    Murakami A; Yakabe K; Yoshidomi K; Sueoka K; Nawata S; Yokoyama Y; Tsuchida S; Al-Mulla F; Sugino N
    Cancer Lett; 2012 Oct; 323(1):69-76. PubMed ID: 22542806
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of astrocyte elevated gene-1: a novel marker of the pathogenesis, progression, and poor prognosis for endometrial cancer.
    Song H; Li C; Lu R; Zhang Y; Geng J
    Int J Gynecol Cancer; 2010 Oct; 20(7):1188-96. PubMed ID: 21495225
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term survival in patients with para-aortic lymph node metastasis with systematic retroperitoneal lymphadenectomy followed by adjuvant chemotherapy in endometrial carcinoma.
    Hiura M; Nogawa T; Matsumoto T; Yokoyama T; Shiroyama Y; Wroblewski J
    Int J Gynecol Cancer; 2010 Aug; 20(6):1000-5. PubMed ID: 20683408
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Para-aortic lymphadenectomy may improve disease-related survival in patients with multipositive pelvic lymph node stage IIIc endometrial cancer.
    Fujimoto T; Nanjyo H; Nakamura A; Yokoyama Y; Takano T; Shoji T; Nakahara K; Yamada H; Mizunuma H; Yaegashi N; Sugiyama T; Kurachi H; Sato A; Tanaka T
    Gynecol Oncol; 2007 Nov; 107(2):253-9. PubMed ID: 17640720
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of focal adhesion kinase in patients with endometrial cancer: a clinicopathologic study.
    Gabriel B; Hasenburg A; Waizenegger M; Orlowska-Volk M; Stickeler E; zur Hausen A
    Int J Gynecol Cancer; 2009 Oct; 19(7):1221-5. PubMed ID: 19823058
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Value of pre-operative serum CA125 level for prediction of prognosis in patients with endometrial cancer.
    Chen YL; Huang CY; Chien TY; Huang SH; Wu CJ; Ho CM
    Aust N Z J Obstet Gynaecol; 2011 Oct; 51(5):397-402. PubMed ID: 21806586
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic significance of tumor-associated macrophages in endometrial adenocarcinoma.
    Kübler K; Ayub TH; Weber SK; Zivanovic O; Abramian A; Keyver-Paik MD; Mallmann MR; Kaiser C; Serçe NB; Kuhn W; Rudlowski C
    Gynecol Oncol; 2014 Nov; 135(2):176-83. PubMed ID: 25173585
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Silencing of UCA1, a poor prognostic factor, inhibited the migration of endometrial cancer cell.
    Lu L; Shen Y; Tseng KF; Liu W; Duan H; Meng W
    Cancer Biomark; 2016 Jun; 17(2):171-7. PubMed ID: 27540975
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stathmin overexpression identifies high-risk patients and lymph node metastasis in endometrial cancer.
    Trovik J; Wik E; Stefansson IM; Marcickiewicz J; Tingulstad S; Staff AC; Njolstad TS; ; Vandenput I; Amant F; Akslen LA; Salvesen HB
    Clin Cancer Res; 2011 May; 17(10):3368-77. PubMed ID: 21242118
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cyr61, a member of ccn (connective tissue growth factor/cysteine-rich 61/nephroblastoma overexpressed) family, predicts survival of patients with endometrial cancer of endometrioid subtype.
    Watari H; Xiong Y; Hassan MK; Sakuragi N
    Gynecol Oncol; 2009 Jan; 112(1):229-34. PubMed ID: 19007976
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased expression of hypoxia-inducible factor 1alpha in type I and type II endometrial carcinomas.
    Pansare V; Munkarah AR; Schimp V; Haitham Arabi M; Saed GM; Morris RT; Ali-Fehmi R
    Mod Pathol; 2007 Jan; 20(1):35-43. PubMed ID: 17099695
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pelvic lymph node count is an important prognostic variable for FIGO stage I and II endometrial carcinoma with high-risk histology.
    Lutman CV; Havrilesky LJ; Cragun JM; Secord AA; Calingaert B; Berchuck A; Clarke-Pearson DL; Soper JT
    Gynecol Oncol; 2006 Jul; 102(1):92-7. PubMed ID: 16406063
    [TBL] [Abstract][Full Text] [Related]  

  • 39. RRBP1 overexpression is associated with progression and prognosis in endometrial endometrioid adenocarcinoma.
    Liu S; Lin M; Ji H; Ding J; Zhu J; Ma R; Meng F
    Diagn Pathol; 2019 Jan; 14(1):7. PubMed ID: 30684972
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changes in Chromatin Structure in Curettage Specimens Identifies High-Risk Patients in Endometrial Cancer.
    Hveem TS; Njølstad TS; Nielsen B; Syvertsen RA; Nesheim JA; Kjæreng ML; Kildal W; Pradhan M; Marcickiewicz J; Tingulstad S; Staff AC; Haugland HK; Eraker R; Oddenes K; Rokne JA; Tjugum J; Lode MS; Amant F; Werner HM; Bjørge L; Albregtsen F; Liestøl K; Salvesen HB; Trovik J; Danielsen HE;
    Cancer Epidemiol Biomarkers Prev; 2017 Jan; 26(1):61-67. PubMed ID: 27587790
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.